| Application no. and date | 13783671.4 (espacenet) (Federated) (European Patent Register), 20130821 | | Patent/reg. no. and date | DK/EP 2888259, 20180307 | | Publication date | 20150701 | | Priority no. and date | GB 201215033, 20120823 | | EP pub. no. and date |
EP 2888259 20150701 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/156908 | | Inventor | BEHNKE, Dirk, Novartis Pharma AG
Werk Klybeck
Postfach
CH-4002 Basel, CH,
CARCACHE, David, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
KOLLER, Manuel, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
ORAIN, David, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
ERTL, Peter, Novartis Pharma AG
Postfach
CH-4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/551 (2006.01) , A61P 1/04 (2006.01) , A61P 25/16 (2006.01) , A61P 25/28 (2006.01) , C07D 471/04 (2006.01) | | Title | Diazepinonderivater egnede til behandling af fragil X-syndrom, parkinsons eller reflux sygdom | | Int. application no. | IB2013056782 | | Int. publication no. | WO2014030128 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
